# Evologics, LLC – FDA Inspection, Mar 20, 2013

Source: https://www.keypedia.com/records/fda_inspections/evologics-llc/b1ba1c6e-7f6e-4d55-b12a-14690c77d920
Source feed: FDA_Inspections

> FDA inspection 823285 of Evologics, LLC, March 20, 2013. Classification: No Action Indicated (NAI). 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 823285
- Company Name: Evologics, LLC
- Inspection Date: 2013-03-20
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1293434 - 2026-06-02
- FDA Inspection 1147505 - 2021-07-27
- [FDA Inspection 1100556 - 2019-08-27](https://www.keypedia.com/records/fda_inspections/evologics-llc/c0ae21bb-6a43-4e43-8bb3-51baf4413205)
- FDA Inspection 993000 - 2016-11-02
- FDA Inspection 695110 - 2010-10-14

Company: https://www.keypedia.com/companies/evologics-llc/cd85e81d-74ac-40c3-a3db-e151014df3cf

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
